Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proshares Trust (ZBIO) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to -$1.22.

  • Zenas BioPharma's EPS (Basic) rose 7569.72% to -$1.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.67, marking a year-over-year increase of 12163.66%. This contributed to the annual value of -$12.22 for FY2024, which is 4959.08% up from last year.
  • Per Zenas BioPharma's latest filing, its EPS (Basic) stood at -$1.22 for Q3 2025, which was up 7569.72% from -$1.25 recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's EPS (Basic) ranged from a high of $2.42 in Q3 2023 and a low of -$24.23 during Q2 2024
  • Over the past 3 years, Zenas BioPharma's median EPS (Basic) value was -$4.28 (recorded in 2024), while the average stood at -$7.59.
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 30743.8% in 2024, then skyrocketed by 9552.82% in 2025.
  • Quarter analysis of 3 years shows Zenas BioPharma's EPS (Basic) stood at -$16.04 in 2023, then surged by 73.3% to -$4.28 in 2024, then surged by 71.52% to -$1.22 in 2025.
  • Its EPS (Basic) stands at -$1.22 for Q3 2025, versus -$1.25 for Q2 2025 and -$0.8 for Q1 2025.